FROM THE ANALYST'S COUCH 15 January 2025 Patricia Giglio

Citeline, New York, NY, USA.

Amanda Micklus

Citeline, New York, NY, USA.

Last year featured slower merger and acquisition (M&A) activity than 2023 and a moderate uptick in alliances. Here, we highlight the trends and key deals. The transactions analysed include those in the biopharma industry, as well as consumer and over-the-counter companies, drug delivery technologies, contract research and clinical trial services, but exclude devices, diagnostics, research tools, animal health and insurance.

Access options

Access Nature and 54 other Nature Portfolio journals

Get Nature+, our best-value online-access subscription

24,99 € / 30 days

cancel any time

Subscription info for Chinese customers

We have a dedicated website for our Chinese customers. Please go to naturechina.com to subscribe to this journal.

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

doi: https://doi.org/10.1038/d41573-025-00013-1

Supplementary Information Supplementary Figure 1 Competing Interests

The authors declare no competing interests.

Jobs